Search Results

There are 13443 results for: content related to: Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature

  1. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Version of Record online : 19 JUN 2012, DOI: 10.1002/mds.25051

  2. You have free access to this content
    Poster Session

    Movement Disorders

    Volume 31, Issue S2, June 2016, Pages: S1–S697,

    Version of Record online : 19 JUN 2016, DOI: 10.1002/mds.26688

  3. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 30, Issue S1, June 2015, Pages: S1–S567,

    Version of Record online : 12 JUN 2015, DOI: 10.1002/mds.26295

  4. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 29, Issue S1, May 2014, Pages: S1–S571,

    Version of Record online : 6 JUN 2014, DOI: 10.1002/mds.25914

  5. The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease

    Movement Disorders

    Volume 26, Issue S3, October 2011, Pages: S2–S41, Susan H. Fox, Regina Katzenschlager, Shen-Yang Lim, Bernard Ravina, Klaus Seppi, Miguel Coelho, Werner Poewe, Olivier Rascol, Christopher G. Goetz and Cristina Sampaio

    Version of Record online : 21 OCT 2011, DOI: 10.1002/mds.23829

  6. Parkinson's Disease

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 13 OCT 2006, DOI: 10.1002/9780470041000.cedt084

  7. Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson´s disease patients with motor complications

    Intervention Review

    The Cochrane Library

    Rebecca Stowe, Natalie Ives, Carl E Clarke, Katherine Deane, van Hilten, Keith Wheatley, Richard Gray, Kelly Handley and Alex Furmston

    Published Online : 7 JUL 2010, DOI: 10.1002/14651858.CD007166.pub2

  8. You have full text access to this OnlineOpen article
    Population pharmacokinetics of levodopa in subjects with advanced Parkinson's disease: levodopa-carbidopa intestinal gel infusion vs. oral tablets

    British Journal of Clinical Pharmacology

    Volume 78, Issue 1, July 2014, Pages: 94–105, Ahmed A. Othman and Sandeep Dutta

    Version of Record online : 20 JUN 2014, DOI: 10.1111/bcp.12324

  9. Catechol-O-Methyltransferase (COMT) Inhibitors in Parkinson's Disease

    Journal of the American Geriatrics Society

    Volume 48, Issue 6, June 2000, Pages: 692–698, Cheryl Waters

    Version of Record online : 27 APR 2015, DOI: 10.1111/j.1532-5415.2000.tb04732.x

  10. Effect of opicapone on levodopa pharmacokinetics, catechol-O-methyltransferase activity and motor fluctuations in patients with Parkinson's disease

    European Journal of Neurology

    Volume 22, Issue 5, May 2015, Pages: 815–e56, J. J. Ferreira, J.-F. Rocha, A. Falcão, A. Santos, R. Pinto, T. Nunes and P. Soares-da-Silva

    Version of Record online : 4 FEB 2015, DOI: 10.1111/ene.12666

  11. Levodopa/DDCI and entacapone is the preferred treatment for Parkinson’s disease patients with motor fluctuations in routine practice: a retrospective, observational analysis of a large French cohort

    European Journal of Neurology

    Volume 15, Issue 7, July 2008, Pages: 643–648, P. Damier, F. Viallet, M. Ziegler, I. Bourdeix and K. Rerat

    Version of Record online : 10 JUN 2008, DOI: 10.1111/j.1468-1331.2008.02165.x

  12. Monoamine oxidase B inhibitors for early Parkinson's disease

    Intervention Review

    The Cochrane Library

    Kristian Turnbull, Robert Caslake, Angus Macleod, Natalie Ives, Rebecca Stowe and Carl Counsell

    Published Online : 20 JUL 2005, DOI: 10.1002/14651858.CD004898.pub2

  13. Catechol-O-methyltransferase inhibitors for levodopa-induced complications in Parkinson's disease

    Intervention Review

    The Cochrane Library

    Katherine Deane, Sybille Spieker and Carl E Clarke

    Published Online : 18 OCT 2004, DOI: 10.1002/14651858.CD004554.pub2

  14. Pharmacotherapy and Treatment of Parkinson's Disease

    Standard Article

    Handbook of Contemporary Neuropharmacology

    Wing Lok Au and Donald B. Calne

    Published Online : 2 MAR 2007, DOI: 10.1002/9780470101001.hcn062

  15. Treatment of levodopa-induced motor complications

    Movement Disorders

    Volume 23, Issue S3, 2008, Pages: S599–S612, Fabrizio Stocchi, Michele Tagliati and C. Warren Olanow

    Version of Record online : 9 SEP 2008, DOI: 10.1002/mds.22052

  16. Population pharmacokinetics of levodopa in patients with Parkinson's disease treated with tolcapone

    Clinical Pharmacology & Therapeutics

    Volume 67, Issue 6, June 2000, Pages: 610–620, Karin Jorga, Ludger Banken, Bärbel Fotteler, Paul Snell and Jean-Louis Steimer

    Version of Record online : 15 JUN 2000, DOI: 10.1067/mcp.2000.106795

  17. You have free access to this content
    How should we treat a patient with early Parkinson’s disease?

    International Journal of Clinical Practice

    Volume 64, Issue 9, August 2010, Pages: 1210–1219, S. Tsouli and S. Konitsiotis

    Version of Record online : 13 JUL 2010, DOI: 10.1111/j.1742-1241.2010.02371.x

  18. Dopamine agonist therapy in early Parkinson's disease

    Intervention Review

    The Cochrane Library

    Rebecca Stowe, Natalie Ives, Carl E Clarke, van Hilten, Joaquim Ferreira, Robert J Hawker, Laila Shah, Keith Wheatley and Richard Gray

    Published Online : 23 APR 2008, DOI: 10.1002/14651858.CD006564.pub2

  19. Levodopa/dopamine replacement strategies in Parkinson's disease—Future directions

    Movement Disorders

    Volume 23, Issue S3, 2008, Pages: S613–S622, C. Warren Olanow

    Version of Record online : 9 SEP 2008, DOI: 10.1002/mds.22061

  20. Levodopa for the treatment of restless legs syndrome

    Intervention Review

    The Cochrane Library

    Hanna Scholz, Claudia Trenkwalder, Ralf Kohnen, Levente Kriston, Dieter Riemann and Magdolna Hornyak

    Published Online : 15 FEB 2011, DOI: 10.1002/14651858.CD005504.pub2